These cells are then incubated with tumours to identify reactive T-cell populations by interferon (IFN)-γ enzyme-linked immune absorbent spot (ELISPOT), intracellular cytokine staining or using multi-colour-labelled major histocompatibility complex (MHC) tetramers for multiplex flow cytometry. This evidence concerns the gene IFNG and neoplasm.